Spots Global Cancer Trial Database for SU011248 Versus Interferon-Alfa As First-Line Systemic Therapy For Patients With Metastatic Renal Cell Carcinoma
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: SU011248 Versus Interferon-Alfa As First-Line Systemic Therapy For Patients With Metastatic Renal Cell Carcinoma
Official Title: A Phase 3, Randomized Study Of SU011248 Versus Interferon-Alfa As First-Line Systemic Therapy For Patients With Metastatic Renal Cell Carcinoma
Study ID: NCT00083889
Conditions
Study Description
Brief Summary: The purpose of this study is to test whether SU011248 has activity and is safe compared to interferon-alfa as first-line therapy in patients with metastatic renal cell carcinoma (RCC).
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Pfizer Investigational Site, Jonesboro, Arkansas, United States
Pfizer Investigational Site, La Jolla, California, United States
Pfizer Investigational Site, La Jolla, California, United States
Pfizer Investigational Site, Los Angeles, California, United States
Pfizer Investigational Site, San Diego, California, United States
Pfizer Investigational Site, San Francisco, California, United States
Pfizer Investigational Site, Aurora, Colorado, United States
Pfizer Investigational Site, New Haven, Connecticut, United States
Pfizer Investigational Site, New Haven, Connecticut, United States
Pfizer Investigational Site, New Haven, Connecticut, United States
Pfizer Investigational Site, Miami, Florida, United States
Pfizer Investigational Site, Miami, Florida, United States
Pfizer Investigational Site, Tampa, Florida, United States
Pfizer Investigational Site, Chicago, Illinois, United States
Pfizer Investigational Site, Maywood, Illinois, United States
Pfizer Investigational Site, Kansas City, Kansas, United States
Pfizer Investigational Site, Overland Park, Kansas, United States
Pfizer Investigational Site, Louisville, Kentucky, United States
Pfizer Investigational Site, Covington, Louisiana, United States
Pfizer Investigational Site, Metairie, Louisiana, United States
Pfizer Investigational Site, Metairie, Louisiana, United States
Pfizer Investigational Site, Baltimore, Maryland, United States
Pfizer Investigational Site, Boston, Massachusetts, United States
Pfizer Investigational Site, Boston, Massachusetts, United States
Pfizer Investigational Site, Detoit, Michigan, United States
Pfizer Investigational Site, Detroit, Michigan, United States
Pfizer Investigational Site, Farmington Hills, Michigan, United States
Pfizer Investigational Site, Minneapolis, Minnesota, United States
Pfizer Investigational Site, Columbus, Mississippi, United States
Pfizer Investigational Site, Corinth, Mississippi, United States
Pfizer Investigational Site, Jackson, Mississippi, United States
Pfizer Investigational Site, Jackson, Mississippi, United States
Pfizer Investigational Site, Southaven, Mississippi, United States
Pfizer Investigational Site, Tupelo, Mississippi, United States
Pfizer Investigational Site, Kansas City, Missouri, United States
Pfizer Investigational Site, Omaha, Nebraska, United States
Pfizer Investigational Site, Lebanon, New Hampshire, United States
Pfizer Investigational Site, Bronx, New York, United States
Pfizer Investigational Site, New York, New York, United States
Pfizer Investigational Site, New York, New York, United States
Pfizer Investigational Site, Cleveland, Ohio, United States
Pfizer Investigational Site, Cleveland, Ohio, United States
Pfizer Investigational Site, Tulsa, Oklahoma, United States
Pfizer Investigational Site, Tulsa, Oklahoma, United States
Pfizer Investigational Site, Tulsa, Oklahoma, United States
Pfizer Investigational Site, Portland, Oregon, United States
Pfizer Investigational Site, Portland, Oregon, United States
Pfizer Investigational Site, Philadelphia, Pennsylvania, United States
Pfizer Investigational Site, Memphis, Tennessee, United States
Pfizer Investigational Site, Memphis, Tennessee, United States
Pfizer Investigational Site, Nashville, Tennessee, United States
Pfizer Investigational Site, Dallas, Texas, United States
Pfizer Investigational Site, Houston, Texas, United States
Pfizer Investigational Site, Tyler, Texas, United States
Pfizer Investigational Site, Salt Lake City, Utah, United States
Pfizer Investigational Site, Seattle, Washington, United States
Pfizer Investigational Site, Seattle, Washington, United States
Pfizer Investigational Site, Madison, Wisconsin, United States
Pfizer Investigational Site, Lismore, New South Wales, Australia
Pfizer Investigational Site, St. Leonards, New South Wales, Australia
Pfizer Investigational Site, South Brisbane, Queensland, Australia
Pfizer Investigational Site, Woodville South, South Australia, Australia
Pfizer Investigational Site, East Melbourne, Victoria, Australia
Pfizer Investigational Site, Perth, Western Australia, Australia
Pfizer Investigational Site, Victoria, , Australia
Pfizer Investigational Site, Rio de Janeiro, RJ, Brazil
Pfizer Investigational Site, Porto Alegre, RS, Brazil
Pfizer Investigational Site, Porto Alegre, RS, Brazil
Pfizer Investigational Site, Calgary, Alberta, Canada
Pfizer Investigational Site, Edmonton, Alberta, Canada
Pfizer Investigational Site, Kelowna, British Columbia, Canada
Pfizer Investigational Site, Vancouver, British Columbia, Canada
Pfizer Investigational Site, Victoria, British Columbia, Canada
Pfizer Investigational Site, London, Ontario, Canada
Pfizer Investigational Site, Toronto, Ontario, Canada
Pfizer Investigational Site, Toronto, Ontario, Canada
Pfizer Investigational Site, Montreal, Quebec, Canada
Pfizer Investigational Site, Quebec, , Canada
Pfizer Investigational Site, Quebec, , Canada
Pfizer Investigational Site, Paris, Cedex 15, France
Pfizer Investigational Site, Lyon, , France
Pfizer Investigational Site, Paris Cedex 13, , France
Pfizer Investigational Site, Rennes, , France
Pfizer Investigational Site, Saint Herblain, , France
Pfizer Investigational Site, Vandoeuvre Les Nancy, , France
Pfizer Investigational Site, Aachen, , Germany
Pfizer Investigational Site, Essen, , Germany
Pfizer Investigational Site, Hannover, , Germany
Pfizer Investigational Site, Ulm, , Germany
Pfizer Investigational Site, Ulm, , Germany
Pfizer Investigational Site, Modena, , Italy
Pfizer Investigational Site, Napoli, , Italy
Pfizer Investigational Site, Pavia, , Italy
Pfizer Investigational Site, Roma, , Italy
Pfizer Investigational Site, Roma, , Italy
Pfizer Investigational Site, Roma, , Italy
Pfizer Investigational Site, Moczowego, Warszawa, Poland
Pfizer Investigational Site, Gdansk, , Poland
Pfizer Investigational Site, Krakow, , Poland
Pfizer Investigational Site, Lodz, , Poland
Pfizer Investigational Site, Lublin, , Poland
Pfizer Investigational Site, Poznan, , Poland
Pfizer Investigational Site, Warszawa, , Poland
Pfizer Investigational Site, Wroclaw, , Poland
Pfizer Investigational Site, Wroclaw, , Poland
Pfizer Investigational Site, Obninsk, Kaluga Region, Russian Federation
Pfizer Investigational Site, Chelyabinsk, , Russian Federation
Pfizer Investigational Site, Moscow, , Russian Federation
Pfizer Investigational Site, Moscow, , Russian Federation
Pfizer Investigational Site, Moscow, , Russian Federation
Pfizer Investigational Site, Saint-Petersburg, , Russian Federation
Pfizer Investigational Site, St. Petersburg, , Russian Federation
Pfizer Investigational Site, Tomsk, , Russian Federation
Pfizer Investigational Site, Hospitalet de Llobregat, Barcelona, Spain
Pfizer Investigational Site, Pamplona, Navarra, Spain
Pfizer Investigational Site, Madrid, , Spain
Pfizer Investigational Site, Madrid, , Spain
Pfizer Investigational Site, Sevilla, , Spain
Pfizer Investigational Site, Whitchurch, Cardiff, United Kingdom
Pfizer Investigational Site, Manchester, Lancashire, United Kingdom
Pfizer Investigational Site, Northwood, Middlesex, United Kingdom
Pfizer Investigational Site, London, , United Kingdom
Pfizer Investigational Site, London, , United Kingdom
Pfizer Investigational Site, Sutton Surrey, , United Kingdom
Contact Details
Name: Pfizer CT.gov Call Center
Affiliation: Pfizer
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
